Hardware, Equipment & Parts
Compare Stocks
2 / 10Stock Comparison
BMI vs XYL
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
BMI vs XYL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Hardware, Equipment & Parts | Industrial - Machinery |
| Market Cap | $3.61B | $27.49B |
| Revenue (TTM) | $917M | $9.09B |
| Net Income (TTM) | $142M | $973M |
| Gross Margin | 41.7% | 38.6% |
| Operating Margin | 20.0% | 13.6% |
| Forward P/E | 26.4x | 20.6x |
| Total Debt | $0.00 | $1.94B |
| Cash & Equiv. | $226M | $1.48B |
BMI vs XYL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Badger Meter, Inc. (BMI) | 100 | 193.7 | +93.7% |
| Xylem Inc. (XYL) | 100 | 171.5 | +71.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BMI vs XYL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BMI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 33 yrs, beta 0.87, yield 1.2%
- Rev growth 10.9%, EPS growth 13.2%, 3Y rev CAGR 17.5%
- 253.6% 10Y total return vs XYL's 204.7%
XYL is the clearest fit if your priority is valuation efficiency.
- PEG 0.90 vs BMI's 1.14
- Lower P/E (20.6x vs 26.4x), PEG 0.90 vs 1.14
- -3.2% vs BMI's -45.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.9% revenue growth vs XYL's 5.5% | |
| Value | Lower P/E (20.6x vs 26.4x), PEG 0.90 vs 1.14 | |
| Quality / Margins | 15.5% margin vs XYL's 10.7% | |
| Stability / Safety | Beta 0.87 vs XYL's 0.92 | |
| Dividends | 1.2% yield, 33-year raise streak, vs XYL's 1.4% | |
| Momentum (1Y) | -3.2% vs BMI's -45.0% | |
| Efficiency (ROA) | 14.5% ROA vs XYL's 5.6%, ROIC 34.5% vs 7.6% |
BMI vs XYL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BMI vs XYL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BMI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XYL is the larger business by revenue, generating $9.1B annually — 9.9x BMI's $917M. Profitability is closely matched — net margins range from 15.5% (BMI) to 10.7% (XYL). On growth, BMI holds the edge at +7.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $917M | $9.1B |
| EBITDAEarnings before interest/tax | $218M | $1.8B |
| Net IncomeAfter-tax profit | $142M | $973M |
| Free Cash FlowCash after capex | $170M | $966M |
| Gross MarginGross profit ÷ Revenue | +41.7% | +38.6% |
| Operating MarginEBIT ÷ Revenue | +20.0% | +13.6% |
| Net MarginNet income ÷ Revenue | +15.5% | +10.7% |
| FCF MarginFCF ÷ Revenue | +18.5% | +10.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.6% | +2.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.6% | +14.5% |
Valuation Metrics
BMI leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 25.6x trailing earnings, BMI trades at a 13% valuation discount to XYL's 29.5x P/E. Adjusting for growth (PEG ratio), BMI offers better value at 1.10x vs XYL's 1.29x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.6B | $27.5B |
| Enterprise ValueMkt cap + debt − cash | $3.4B | $27.9B |
| Trailing P/EPrice ÷ TTM EPS | 25.60x | 29.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 26.37x | 20.56x |
| PEG RatioP/E ÷ EPS growth rate | 1.10x | 1.29x |
| EV / EBITDAEnterprise value multiple | 15.54x | 15.54x |
| Price / SalesMarket cap ÷ Revenue | 3.94x | 3.04x |
| Price / BookPrice ÷ Book value/share | 5.08x | 2.40x |
| Price / FCFMarket cap ÷ FCF | 21.30x | 30.21x |
Profitability & Efficiency
BMI leads this category, winning 6 of 7 comparable metrics.
Profitability & Efficiency
BMI delivers a 19.9% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $9 for XYL. On the Piotroski fundamental quality scale (0–9), XYL scores 6/9 vs BMI's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +19.9% | +8.5% |
| ROA (TTM)Return on assets | +14.5% | +5.6% |
| ROICReturn on invested capital | +34.5% | +7.6% |
| ROCEReturn on capital employed | +24.1% | +8.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | — | 0.17x |
| Net DebtTotal debt minus cash | -$226M | $463M |
| Cash & Equiv.Liquid assets | $226M | $1.5B |
| Total DebtShort + long-term debt | $0 | $1.9B |
| Interest CoverageEBIT ÷ Interest expense | — | 49.32x |
Total Returns (Dividends Reinvested)
XYL leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BMI five years ago would be worth $13,948 today (with dividends reinvested), compared to $10,262 for XYL. Over the past 12 months, XYL leads with a -3.2% total return vs BMI's -45.0%. The 3-year compound annual growth rate (CAGR) favors XYL at 3.8% vs BMI's -2.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -30.3% | -15.3% |
| 1-Year ReturnPast 12 months | -45.0% | -3.2% |
| 3-Year ReturnCumulative with dividends | -8.2% | +11.9% |
| 5-Year ReturnCumulative with dividends | +39.5% | +2.6% |
| 10-Year ReturnCumulative with dividends | +253.6% | +204.7% |
| CAGR (3Y)Annualised 3-year return | -2.8% | +3.8% |
Risk & Volatility
Evenly matched — BMI and XYL each lead in 1 of 2 comparable metrics.
Risk & Volatility
BMI is the less volatile stock with a 0.87 beta — it tends to amplify market swings less than XYL's 0.92 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. XYL currently trades 75.0% from its 52-week high vs BMI's 47.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.84x | 0.90x |
| 52-Week HighHighest price in past year | $256.08 | $154.27 |
| 52-Week LowLowest price in past year | $112.09 | $114.15 |
| % of 52W HighCurrent price vs 52-week peak | +47.9% | +75.0% |
| RSI (14)Momentum oscillator 0–100 | 39.9 | 45.4 |
| Avg Volume (50D)Average daily shares traded | 560K | 2.1M |
Analyst Outlook
Evenly matched — BMI and XYL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BMI as "Hold" and XYL as "Hold". Consensus price targets imply 40.4% upside for BMI (target: $172) vs 31.1% for XYL (target: $152). For income investors, XYL offers the higher dividend yield at 1.39% vs BMI's 1.20%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $172.14 | $151.57 |
| # AnalystsCovering analysts | 18 | 40 |
| Dividend YieldAnnual dividend ÷ price | +1.2% | +1.4% |
| Dividend StreakConsecutive years of raises | 33 | 15 |
| Dividend / ShareAnnual DPS | $1.47 | $1.60 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +0.1% |
BMI leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). XYL leads in 1 (Total Returns). 2 tied.
BMI vs XYL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BMI or XYL a better buy right now?
For growth investors, Badger Meter, Inc.
(BMI) is the stronger pick with 10. 9% revenue growth year-over-year, versus 5. 5% for Xylem Inc. (XYL). Badger Meter, Inc. (BMI) offers the better valuation at 25. 6x trailing P/E (26. 4x forward), making it the more compelling value choice. Analysts rate Badger Meter, Inc. (BMI) a "Hold" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BMI or XYL?
On trailing P/E, Badger Meter, Inc.
(BMI) is the cheapest at 25. 6x versus Xylem Inc. at 29. 5x. On forward P/E, Xylem Inc. is actually cheaper at 20. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Xylem Inc. wins at 0. 90x versus Badger Meter, Inc. 's 1. 14x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BMI or XYL?
Over the past 5 years, Badger Meter, Inc.
(BMI) delivered a total return of +39. 5%, compared to +2. 6% for Xylem Inc. (XYL). Over 10 years, the gap is even starker: BMI returned +242. 5% versus XYL's +200. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BMI or XYL?
By beta (market sensitivity over 5 years), Badger Meter, Inc.
(BMI) is the lower-risk stock at 0. 84β versus Xylem Inc. 's 0. 90β — meaning XYL is approximately 6% more volatile than BMI relative to the S&P 500.
05Which is growing faster — BMI or XYL?
By revenue growth (latest reported year), Badger Meter, Inc.
(BMI) is pulling ahead at 10. 9% versus 5. 5% for Xylem Inc. (XYL). On earnings-per-share growth, the picture is similar: Badger Meter, Inc. grew EPS 13. 2% year-over-year, compared to 7. 4% for Xylem Inc.. Over a 3-year CAGR, XYL leads at 17. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BMI or XYL?
Badger Meter, Inc.
(BMI) is the more profitable company, earning 15. 5% net margin versus 10. 6% for Xylem Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BMI leads at 20. 0% versus 13. 5% for XYL. At the gross margin level — before operating expenses — BMI leads at 41. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BMI or XYL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Xylem Inc. (XYL) is the more undervalued stock at a PEG of 0. 90x versus Badger Meter, Inc. 's 1. 14x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Xylem Inc. (XYL) trades at 20. 6x forward P/E versus 26. 4x for Badger Meter, Inc. — 5. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BMI: 40. 4% to $172. 14.
08Which pays a better dividend — BMI or XYL?
All stocks in this comparison pay dividends.
Xylem Inc. (XYL) offers the highest yield at 1. 4%, versus 1. 2% for Badger Meter, Inc. (BMI).
09Is BMI or XYL better for a retirement portfolio?
For long-horizon retirement investors, Badger Meter, Inc.
(BMI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 84), 1. 2% yield, +242. 5% 10Y return). Both have compounded well over 10 years (BMI: +242. 5%, XYL: +200. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BMI and XYL?
These companies operate in different sectors (BMI (Technology) and XYL (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.